Latest News about ABBV
Recent news which mentions ABBV
Better Growth Stock: AbbVie vs. Abbott Laboratories
December 21, 2023
From Motley Fool
7 Blue-Chip Dividend Stocks to Buy Before Dec. 31
December 19, 2023
From InvestorPlace
7 ‘Bulletproof’ Stocks to Buy Ahead of a Wild New Year
December 19, 2023
From InvestorPlace
Better Income Stock: AT&T or AbbVie?
December 17, 2023
From Motley Fool
3 of the Most Attractive Dividend Stocks in the Pharma Space
December 17, 2023
From InvestorPlace
3 Fantastic Stocks That Could Enjoy a Santa Claus Rally
December 16, 2023
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
December 14, 2023
From Benzinga
Decoding AbbVie's Options Activity: What's the Big Picture?
December 14, 2023
Tickers
ABBV
From Benzinga
The 7 Most Undervalued Growth Stocks to Buy in December
December 13, 2023
From InvestorPlace
$100 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today
December 13, 2023
Tickers
ABBV
From Benzinga
Economic Safety Nets: 7 Defensive Stocks Providing Portfolio Stability
December 13, 2023
From InvestorPlace
Botox And Similar Injections Have Associated Risks: Consumer Group Pushes for Stronger Warnings
December 12, 2023
From Benzinga
From Motley Fool
From Benzinga
The 3 Best Cheap Stocks to Buy in December
December 10, 2023
From InvestorPlace
From Motley Fool
AbbVie Just Announced 2 Big Acquisitions: Is This Dividend King a No-Brainer Buy Right Now?
December 10, 2023
From Motley Fool
3 Dividend Stocks You Can Safely Hold for Decades
December 09, 2023
From Motley Fool
Better Dividend Stock: AbbVie vs. Medical Properties Trust
December 09, 2023
From Motley Fool
3 High-Yielding Dividend Stocks That Are Near Their 52-Week Lows
December 08, 2023
From Motley Fool
From Motley Fool
Healthcare Gems: 3 Essential Long-Term Stock Picks
December 07, 2023
From InvestorPlace
AbbVie's New $9B Neuroscience Space Deal Might Attract FTC Scrutiny, Analyst Signals
December 07, 2023
From Benzinga
Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 07, 2023
From Benzinga
Why Cerevel Therapeutics Stock Is Higher
December 07, 2023
From Benzinga